Subsequently, ccRCC cells were treated with the HDAC10 inhibitor Quisinostat, and the expression of downstream proteins in the Notch-1 signaling pathway and PTEN-related proteins was assessed by Western blotting. The gene discussed is PTEN; the disease is nonpapillary renal cell carcinoma.